AbbVie Declares Quarterly Dividend
Rhea-AI Summary
Positive
- Quarterly dividend of $1.64 per share maintains consistent shareholder returns
- Impressive 310% dividend growth since 2013 demonstrates strong financial performance
- Inclusion in S&P Dividend Aristocrats Index reflects reliable dividend growth history
Negative
- None.
News Market Reaction – ABBV
On the day this news was published, ABBV declined 0.10%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
The cash dividend is payable August 15, 2025, to stockholders of record at the close of business on July 15, 2025.
Since the company's inception in 2013, AbbVie has increased its dividend by 310 percent. AbbVie is a member of the S&P Dividend Aristocrats Index, which tracks companies that have annually increased their dividend for at least 25 consecutive years.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology, neuroscience and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter) and YouTube.
Media: | Investors: |
Gabby Tarbert | Liz Shea |
(224) 244-0111 | (847) 935-2211 |
View original content:https://www.prnewswire.com/news-releases/abbvie-declares-quarterly-dividend-302486685.html
SOURCE AbbVie
FAQ
What is AbbVie's (ABBV) quarterly dividend payment for Q3 2025?
How much has AbbVie's dividend increased since 2013?
When is the record date for AbbVie's Q3 2025 dividend?
Is AbbVie (ABBV) a Dividend Aristocrat?